Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by husk16on Jun 14, 2013 2:36pm
239 Views
Post# 21526251

RE: RE: Lipator

RE: RE: Lipator

I agree BDA.  RVX doesnt need to hit a home run (some of the regulars have posted at what levels we may see in plaque regression). 

What is important is when the news does come out.  Take some time and digest the info, listen to the conference call afterwards.

At this moment I dont think the market is expecting a home run either.  If it was at $5+ dollars maybe.  But it is sitting in the low $2s. 

So what will the market say after only decent results?

As I have been rereading more and more posts from the last few years.  One very important thing to consider.

The Science (RVX-208) has remained positive throughout all testing

Management may have made many, many mistakes.  Bad luck with poorly timed negative press.  Poor financings, etc

But if you were brand new to RVX, never looked at the Share Price, was only given the scientific data.  Would you not be more excited about the prospects of RVX-208 now vs 2,5,8 years ago????????

Bullboard Posts